Related Experiment Video
Updated: May 12, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Cost-effectiveness analysis of a pertussis vaccination programme for Japan considering intergenerational infection
Tomoya Itatani1, Sachiko Shimizu, Maya Iwasa
1Department of Total Health Promotion Science, Graduate School of Medicine, Osaka University, 1-7 Yamadaoka, Suita, Osaka 565-0871, Japan. itatani@sahs.med.osaka-u.ac.jp
Insights
Adolescent pertussis vaccination programs are not cost-effective. However, one-time adolescent diphtheria-tetanus-acellular pertussis (DTaP) vaccination becomes cost-effective when considering intergenerational infection, highlighting the need for accurate pertussis incidence data.
Area of Science:
- Public Health
- Epidemiology
- Health Economics
Background:
- Pertussis (whooping cough) incidence is rising in adolescents and adults, with sporadic outbreaks in Japan.
- Intergenerational transmission of pertussis from adolescents/adults to infants is a significant concern.
Purpose of the Study:
- To evaluate the cost-effectiveness of alternative adolescent pertussis vaccination programs compared to the conventional diphtheria-tetanus (DT) vaccine.
- To incorporate the risk of intergenerational pertussis infection into the analysis.
Main Methods:
- A state-transition Markov model was used to assess four vaccination strategies: DT, adolescent DT-acellular pertussis (DTaP), DTaP with booster, and DTaP with parental vaccination.
- The model estimated costs, life expectancy, quality-adjusted life expectancy, BCR, and ICER from a societal perspective.
- Intergenerational infection from adolescents/adults to infants was factored into the model.
Main Results:
- At an incidence of 25 per 100,000, the incremental cost-effectiveness ratios (ICERs) for DTaP and additional DTaP for parents were 3,576,072 JPY and 240,055,273 JPY, respectively, when intergenerational transmission was considered.
- The DTaP with booster strategy was dominated, indicating it was less cost-effective than other options.
Conclusions:
- Currently, alternative pertussis vaccination programs are not cost-effective.
- One-time adolescent DTaP vaccination demonstrates cost-effectiveness when intergenerational infection is considered.
- Accurate pertussis incidence reporting is crucial, as it significantly impacts cost-effectiveness analysis outcomes.
Objective:
The incidence of pertussis in adolescence and adulthood has been increasing, and pertussis outbreaks have occurred sporadically in Japan. The risk of intergenerational infection of pertussis is of concern. The aim of this study is to assess the cost-effectiveness of alternative vaccination programmes for replacing the conventional diphtheria-tetanus (DT) vaccine programme administered in adolescence, considering the risk of intergenerational infection.
Methods:
We examined the cost-effectiveness of 4 pertussis vaccination programmes: (1) one-time adolescent DT vaccination (DT); (2) one-time adolescent DT-acellular pertussis (DTaP) vaccination; (3) one-time adolescent DTaP with decennial booster (DTaP+booster); and (4) one-time adolescent DTaP with additional vaccination targeted at parents with infants (additional DTaP for parents). We adapted a state-transition Markov model to estimate the costs and effectiveness of vaccination in the adolescent and adult cohorts and then considered intergenerational infection from adolescents/adults to infants. We assumed a societal perspective to estimate results and expressed these in terms of cost, life expectancy, quality-adjusted life expectancy, benefit-cost ratio (BCR), and incremental cost-effectiveness ratio (ICER).
Results:
At an incidence of 25 per 100,000, the ICERs of the DTaP and additional DTaP for parents strategies were 3,576,072 JPY and 240,055,273 JPY, respectively, when intergenerational transmission of infection was considered. The ICER for the DTaP+booster strategy was dominated.
Major Conclusion:
Alternative vaccination programmes are not currently cost-effective. If intergenerational infection considered, one-time adolescent DTaP vaccination is cost-effective. More accurate reports of pertussis incidence are required as the results of cost-effectiveness analyses of vaccination vary greatly depending on incidence.
More Related Videos
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Related Concept Videos
Vaccinations
Statistical Methods for Analyzing Epidemiological Data
Bias in Epidemiological Studies
Causality in Epidemiology
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...